OBJECTIVES: We studied the signal transduction of atrial structural remodeling that contributes to the pathogenesis of atrial fibrillation (AF). BACKGROUND: Fibrosis is a hallmark of arrhythmogenic structural remodeling, but the underlying molecular mechanisms are incompletely understood. METHODS: We performed transcriptional profiling of left atrial myocardium from patients with AF and sinus rhythm and applied cultured primary cardiac cells and transgenic mice with overexpression of constitutively active V12Rac1 (RacET) in which AF develops at old age to characterize mediators of the signal transduction of atrial remodeling. RESULTS: Left atrial myocardium from patients with AF showed a marked up-regulation of connective tissue growth factor (CTGF) expression compared with sinus rhythm patients. This was associated with increased fibrosis, nicotinamide adenine dinucleotide phosphate oxidase, Rac1 and RhoA activity, up-regulation of N-cadherin and connexin 43 (Cx43) expression, and increased angiotensin II tissue concentration. In neonatal rat cardiomyocytes and fibroblasts, a specific small molecule inhibitor of Rac1 or simvastatin completely prevented the angiotensin II-induced up-regulation of CTGF, Cx43, and N-cadherin expression. Transfection with small-inhibiting CTGF ribonucleic acid blocked Cx43 and N-cadherin expression. RacET mice showed up-regulation of CTGF, Cx43, and N-cadherin protein expression. Inhibition of Rac1 by oral statin treatment prevented these effects, identifying Rac1 as a key regulator of CTGF in vivo. CONCLUSIONS: The data identify CTGF as an important mediator of atrial structural remodeling during AF. Angiotensin II activates CTGF via activation of Rac1 and nicotinamide adenine dinucleotide phosphate oxidase, leading to up-regulation of Cx43, N-cadherin, and interstitial fibrosis and therefore contributing to the signal transduction of atrial structural remodeling. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
OBJECTIVES: We studied the signal transduction of atrial structural remodeling that contributes to the pathogenesis of atrial fibrillation (AF). BACKGROUND:Fibrosis is a hallmark of arrhythmogenic structural remodeling, but the underlying molecular mechanisms are incompletely understood. METHODS: We performed transcriptional profiling of left atrial myocardium from patients with AF and sinus rhythm and applied cultured primary cardiac cells and transgenic mice with overexpression of constitutively active V12Rac1 (RacET) in which AF develops at old age to characterize mediators of the signal transduction of atrial remodeling. RESULTS: Left atrial myocardium from patients with AF showed a marked up-regulation of connective tissue growth factor (CTGF) expression compared with sinus rhythm patients. This was associated with increased fibrosis, nicotinamide adenine dinucleotide phosphate oxidase, Rac1 and RhoA activity, up-regulation of N-cadherin and connexin 43 (Cx43) expression, and increased angiotensin II tissue concentration. In neonatal rat cardiomyocytes and fibroblasts, a specific small molecule inhibitor of Rac1 or simvastatin completely prevented the angiotensin II-induced up-regulation of CTGF, Cx43, and N-cadherin expression. Transfection with small-inhibiting CTGF ribonucleic acid blocked Cx43 and N-cadherin expression. RacET mice showed up-regulation of CTGF, Cx43, and N-cadherin protein expression. Inhibition of Rac1 by oral statin treatment prevented these effects, identifying Rac1 as a key regulator of CTGF in vivo. CONCLUSIONS: The data identify CTGF as an important mediator of atrial structural remodeling during AF. Angiotensin II activates CTGF via activation of Rac1 and nicotinamide adenine dinucleotide phosphate oxidase, leading to up-regulation of Cx43, N-cadherin, and interstitial fibrosis and therefore contributing to the signal transduction of atrial structural remodeling. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Authors: Myong-Ho Jeong; Hyun-Ji Kim; Jung-Hoon Pyun; Kyu-Sil Choi; Dong I Lee; Soroosh Solhjoo; Brian O'Rourke; Gordon F Tomaselli; Dong Seop Jeong; Hana Cho; Jong-Sun Kang Journal: Proc Natl Acad Sci U S A Date: 2017-02-02 Impact factor: 11.205
Authors: Honghuang Lin; Elena V Dolmatova; Michael P Morley; Kathryn L Lunetta; David D McManus; Jared W Magnani; Kenneth B Margulies; Hakon Hakonarson; Federica del Monte; Emelia J Benjamin; Thomas P Cappola; Patrick T Ellinor Journal: Heart Rhythm Date: 2013-10-28 Impact factor: 6.343
Authors: David D McManus; Kahraman Tanriverdi; Honghuang Lin; Nada Esa; Menhel Kinno; Divakar Mandapati; Stanley Tam; Okike N Okike; Patrick T Ellinor; John F Keaney; J Kevin Donahue; Emelia J Benjamin; Jane E Freedman Journal: Heart Rhythm Date: 2014-10-09 Impact factor: 6.343
Authors: Honghuang Lin; Roby Joehanes; Luke C Pilling; Josée Dupuis; Kathryn L Lunetta; Sai-Xia Ying; Emelia J Benjamin; Dena Hernandez; Andrew Singleton; David Melzer; Peter J Munson; Daniel Levy; Luigi Ferrucci; Joanne M Murabito Journal: Genomics Date: 2014-10-13 Impact factor: 5.736
Authors: Tanja K Rudolph; Thorben Ravekes; Anna Klinke; Kai Friedrichs; Martin Mollenhauer; Michaela Pekarova; Gabriela Ambrozova; Hana Martiskova; Jatinder-Jit Kaur; Bianca Matthes; Alex Schwoerer; Steven R Woodcock; Lukas Kubala; Bruce A Freeman; Stephan Baldus; Volker Rudolph Journal: Cardiovasc Res Date: 2015-11-23 Impact factor: 10.787